BSEM 8-K 2026-09-30

BioStem Technologies, Inc. (BSEM) 8-K dated 2026-09-30 — accession 0001193125-26-409169. This URL is the filing, not the BSEM hub.

BioStem Technologies, Inc. (BSEM) is a biotechnology company listed on US.

BioStem Technologies, Inc. filed a 8-K on 2026-09-30. Accession 0001193125-26-409169.

Cached items: 1.01, 3.02, 7.01, 8.01, 9.01. EDGAR remains the official archive; Lician keeps this accession as its own indexable page so Google can recrawl the form, not a ticker dump.

Latest reported BSEM revenue for 2026-06-30 was $7.9M. Net income was -$9.0M. Revenue was down 70.7% from 2025-06-30 to 2026-06-30. BSEM currently screens at market cap $211.2M and trailing P/E 8.5.

Not investment advice. The BSEM SEC hub lists recent forms. The stock page is the research view.